CIK 0001557376 · Non-accelerated filer<br>Smaller reporting company
Zeo ScientifiX, Inc.
Sign in to watch- Ticker
- ZEOX
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 474180540
- Phone
- 888-963-7881
- Business address
- 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL, 33314
- Former names
- Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 70 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-07 | Skycrest Holdings, LLC 10% owner | Purchase | +320,710 | $0.01 | $3K | 51,720,710 |
| 2023-06-29 | Leider Harry L. Chief Executive Officer | Purchase | +500,000 | $0.01 | $5K | 1,049,450 |
| 2023-06-29 | Skycrest Holdings, LLC 10% owner | Purchase | +200,000 | $0.01 | $2K | 51,400,000 |
| 2023-06-29 | Leider Harry L. Chief Executive Officer | Purchase | +500,000 | $0.01 | $5K | 1,049,450 |
| 2023-06-28 | Leider Harry L. Chief Executive Officer | Purchase | +549,450 | $0.01 | $5K | 549,450 |
| 2023-06-28 | Skycrest Holdings, LLC 10% owner | Purchase | +400,000 | $0.01 | $4K | 51,200,000 |
| 2023-06-28 | Leider Harry L. Chief Executive Officer | Purchase | +549,450 | $0.10 | $54K | 549,450 |
| 2023-06-26 | Skycrest Holdings, LLC 10% owner | Purchase | +800,000 | $0.01 | $7K | 50,800,000 |
| 2022-10-31 | Sinnreich Matthew Phillip President and Acting CEO | Other disposition | −6,976,000 | 0 | ||
| 2022-10-31 | Sinnreich Matthew Phillip President and Acting CEO | Other disposition | −6,979 | 0 | ||
| 2022-10-13 | Sinnreich Matthew Phillip President and Acting CEO | Sale | −20,000 | $0.04 | $800 | 6,976,000 |
| 2022-08-19 | Shapiro George Craig Chief Medical Officer | Grant or award · Warrant to Purchase Common Stock | +3,150,000 | 3,150,000 | ||
| 2022-08-19 | BOTHWELL IAN T Chief Financial Officer | Grant or award · Warrant to purchase Common Stock | +30,000,000 | 30,000,000 | ||
| 2021-10-29 | Mitrani Albert Chief Executive Officer | Other disposition | −15,000,000 | 151,790,190 | ||
| 2021-10-29 | Mitrani Albert Chief Executive Officer | Other acquisition | +15,000,000 | 166,790,190 | ||
| 2021-10-29 | MITRANI MARIA INES Chief Science Officer | Other disposition | −15,000,000 | 101,707,890 | ||
| 2021-10-29 | MITRANI MARIA INES Chief Science Officer | Other acquisition | +15,000,000 | 116,707,890 | ||
| 2021-10-29 | Shapiro George Craig Chief Medical Officer | Other disposition | −5,000,000 | 75,604,187 | ||
| 2021-10-29 | Shapiro George Craig Chief Medical Officer | Other acquisition | +5,000,000 | 80,604,187 | ||
| 2021-10-29 | BOTHWELL IAN T Chief Financial Officer | Other disposition | −15,000,000 | 133,018,726 |
Page 5 of 12 · 240 trades